Growth Metrics

Lifecore Biomedical, Inc. \De\ (LFCR) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $8.0 million.

  • Lifecore Biomedical, Inc. \De\'s Accumulated Depreciation & Amortization rose 91.78% to $8.0 million in Q2 2025 from the same period last year, while for May 2025 it was $8.0 million, marking a year-over-year increase of 91.78%. This contributed to the annual value of $8.0 million for FY2025, which is 91.78% up from last year.
  • As of Q2 2025, Lifecore Biomedical, Inc. \De\'s Accumulated Depreciation & Amortization stood at $8.0 million, which was up 91.78% from $2.1 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Accumulated Depreciation & Amortization registered a high of $19.9 million during Q2 2021, and its lowest value of $2.0 million during Q4 2023.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Accumulated Depreciation & Amortization had a median value of $7.6 million in 2022 and averaged $8.2 million.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first surged by 1188.68% in 2021, then tumbled by 8090.8% in 2024.
  • Lifecore Biomedical, Inc. \De\'s Accumulated Depreciation & Amortization (Quarter) stood at $11.0 million in 2021, then crashed by 33.65% to $7.3 million in 2022, then plummeted by 72.76% to $2.0 million in 2023, then grew by 2.87% to $2.0 million in 2024, then soared by 292.71% to $8.0 million in 2025.
  • Its last three reported values are $8.0 million in Q2 2025, $2.1 million for Q1 2025, and $2.0 million during Q4 2024.